Clinical Trial

Cerebral Autoregulation in Patients With Symptomatic Cerebral Atherosclerotic Stenosis

Study acronym: CASCAS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 1, 2024 (before its estimated December 24, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this multi-center prospective observational study within a cohort of symptomatic cerebral atherosclerotic stenosis (sCAS) patients, 850 subjects were planed to be enrolled to explore the relationship between cerebral autoregulation (CA) and stroke recurrence, determine the threshold values of CA parameter for predicting stroke recurrence associated with particular stenosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-08-29; most recent amendment 2024-02-29.
Trial Details
NCT Number NCT05028855
Lead Sponsor Yi Yang
Collaborators: Shenzhen Second People's Hospital, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of University of South China, Eighth Affiliated Hospital, Sun Yat-sen University, The First Affiliated Hospital of Hebei North University, Qilu Hospital of Shandong University, The Affiliated Hospital of Qingdao University, The Affiliated Hospital of Yanbian University
Conditions Cerebrovascular Stroke, Cerebral Artery Stenosis
Enrollment 850 participants
Start Date 2017-01-14
Primary Completion 2025-12-24 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-01